Technology | Stethoscopes | November 19, 2015

Smart ECG Stethoscope Attachment Improves the Cardio-Diagnostic Processes

FDA-cleared device combines ECG, digital auscultation and mobile app integration with any existing stethoscope

Rijuven, CardioSleeve for Pediatrics, FDA clearance, stethoscopes

Image courtesy of Rijuven

November 19, 2015 — Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug Administration (FDA)-cleared device that adds electrocardiogram (ECG) capabilities to transform any existing stethoscope into a smart, mobile-connected device. The system is complete with three-lead ECG, digital auscultation and real-time digital analysis optimized for pediatric care. With CardioSleeve, pediatricians and clinicians can quickly and accurately visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.

Through the synchronization of digital heart sound with ECG, CardioSleeve for Pediatrics makes all-new functionality possible, such as advanced murmur detection analysis at times when restless patients, noisy environments and rapid heart rate can make examinations challenging. CardioSleeve murmur detection analysis aids in the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates up to 180 beats per minute.

Pediatricians and clinicians simply attach the CardioSleeve to an existing stethoscope. The device quickly and accurately acquires the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis. This allows for the creation of the Systolic Performance Index, a measure of ejection fraction, critical to identifying heart failure.

CardioSleeve for Pediatrics and its companion mobile app features:

  • Digital auscultation with ECG;
  • Murmur detection and analysis at beats up to 180 BPM;
  • High fidelity three-lead ECG;
  • Systolic Performance Index;
  • Digital caliper;
  • FDA clearance for both device and analysis;
  • HIPAA-secure data transfer and cloud-based electronic medical record (EMR);
  • Wireless Bluetooth connectivity;
  • IOS, Android and PC compatibility;
  • Easy attachment to any traditional stethoscope; and
  • Dry-contact and biocompatible surfaces.

CardioSleeve for Pediatrics is part of the Rijuven i2Dtx platform. i2Dtx is a comprehensive, portable, cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination.

The i2DTX platform includes a CardioSleeve and connected devices including an otoscope, pulse ox, IR thermometer and blood pressure cuff. Optional additions include a weight scale, spirometer, ultrasound, and blood glucose monitor. All devices can be wirelessly deployed to assess patients at any point of care. i2Dtx connects vitals, diagnostic, and lab devices with live notes, real-time consults, high definition (HD) photos for visual exams and a complete EMR report both in the facility and remotely.

For more information: www.rijuven.com

Related Content

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.